Federated Hermes’s Edgewise Therapeutics EWTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.15M | Buy |
316,500
+316,420
| +395,525% | +$4.15M | 0.01% | 769 |
|
|
2025
Q1 | $1.76K | Sell |
80
-27
| -25% | -$594 | ﹤0.01% | 1959 |
|
|
2024
Q4 | $2.86K | Sell |
107
-2
| -2% | -$53 | ﹤0.01% | 1949 |
|
|
2024
Q3 | $2.91K | Sell |
109
-46,125
| -100% | -$1.23M | ﹤0.01% | 1913 |
|
|
2024
Q2 | $833K | Buy |
+46,234
| New | +$833K | ﹤0.01% | 1170 |
|
|
2023
Q4 | – | Sell |
-355
| Closed | -$2.03K | – | 2086 |
|
|
2023
Q3 | $2.03K | Sell |
355
-2
| -0.6% | -$11 | ﹤0.01% | 1968 |
|
|
2023
Q2 | $2.77K | Sell |
357
-8,746
| -96% | -$67.8K | ﹤0.01% | 1974 |
|
|
2023
Q1 | $60.7K | Buy |
9,103
+1,392
| +18% | +$9.29K | ﹤0.01% | 1718 |
|
|
2022
Q4 | $68.9K | Buy |
+7,711
| New | +$68.9K | ﹤0.01% | 1679 |
|
|
2022
Q1 | – | Sell |
-147,075
| Closed | -$2.25M | – | 2231 |
|
|
2021
Q4 | $2.25M | Sell |
147,075
-552,925
| -79% | -$8.45M | ﹤0.01% | 1015 |
|
|
2021
Q3 | $11.6M | Hold |
700,000
| – | – | 0.02% | 606 |
|
|
2021
Q2 | $14.9M | Buy |
700,000
+83,276
| +14% | +$1.78M | 0.03% | 550 |
|
|
2021
Q1 | $20M | Buy |
+616,724
| New | +$20M | 0.04% | 496 |
|